Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Horizon announces new TEPEZZA pharmacokinetic data and Thyroid Eye Disease (TED) data published in the Journal of the Endocrine Society.
Horizon Therapeutics To Present New Data On Pharmacokinetic Profile Of TEPEZZA
12:00am, Thursday, 14'th May 2020The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
Horizon Pharma Shares Volatile On Volume Spike; Hearing CEO To Appear On CNBC Shortly
12:00am, Tuesday, 12'th May 2020U.S. Physician Survey Illustrates the Devastating Impact of Thyroid Eye Disease on Patient Quality of Life
04:00pm, Monday, 11'th May 2020
Horizon announces a U.S. physician survey illustrating the devastating impact of Thyroid Eye Disease (TED) on patient quality of life.
Morgan Stanley Maintains Overweight on Horizon Therapeutics, Raises Price Target to $50
12:00am, Friday, 08'th May 2020The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Edited Transcript of HZNP earnings conference call or presentation 6-May-20 12:00pm GMT
08:51pm, Wednesday, 06'th May 2020
Q1 2020 Horizon Therapeutics PLC Earnings Call
Why Horizon Therapeutics Is Soaring Today
04:39pm, Wednesday, 06'th May 2020
Shares of Horizon Therapeutics (NASDAQ: HZNP) are up by 16% as of 12:03 p.m. EDT on Wednesday following the company's release of its first-quarter earnings report. Investors were impressed with Horiz
Horizon Therapeutics Breaks Out
02:43pm, Wednesday, 06'th May 2020
Horizon Therapeutics gapped out of a four-month consolidation after reporting earnings that were more than double expectations
Why These 8 Pharma Stocks Are Outplaying 90% Of The Stock Market
01:34pm, Wednesday, 06'th May 2020
Pharmaceutical stocks dipped by a double-digit percentage in the first four months of 2020, trailing their biotech brethren. Still, there are standout companies in the industry group.
Earnings, Horizon Therapeutics, Biopharma, Biotech, Conference Call
